CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-01 | DiMarchi Richard D Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2017-06-01 | HOLUBIAK MYRON Z Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2017-06-01 | RINGO WILLIAM R Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2017-06-01 | LEWIS ALAN Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2017-05-12 | RINGO WILLIAM R Director | Sale | −3,461 | $22.00 | $76K | 0 |
| 2017-05-10 | RINGO WILLIAM R Director | Option exercise | +5,000 | $7.20 | $36K | 25,465 |
| 2017-05-10 | RINGO WILLIAM R Director | Shares withheld for taxes | −1,539 | $23.39 | $36K | 23,926 |
| 2017-05-10 | RINGO WILLIAM R Director | Gift | −3,461 | 20,465 | ||
| 2017-05-10 | RINGO WILLIAM R Director | Gift | +3,461 | 3,461 | ||
| 2017-05-10 | RINGO WILLIAM R Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 59,000 | ||
| 2017-03-29 | BARRETT DAVID JONATHAN See Remarks | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-03-29 | Small Derek A CEO, President and Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2017-03-29 | Colonno Richard James Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2017-03-29 | Rollins Thomas E See Remarks | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-03-29 | Lopatin Uri A Chief Med. Off., VP Res. Dev. | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2016-06-02 | Rollins Thomas E See Remarks | Grant or award · Stock Option (Right to Buy) | +40,263 | 40,263 | ||
| 2016-06-02 | AUERBACH MARK Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-06-02 | RINGO WILLIAM R Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-06-02 | DiMarchi Richard D Director | Grant or award · Stock Option (Right to Buy | +10,000 | 10,000 | ||
| 2016-06-02 | LEWIS ALAN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 17 of 22 · 434 trades